Published:
Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management
HYDERABAD, India andWESTBOROUGH, Mass., June 26 /PRNewswire-FirstCall/ --
Satyam Computer Services Ltd. (NYSE: SAY), a leading global consulting and
information technology services provider, announced today that it has formed
an alliance with Sciformix Corporation, aWestborough, Mass.-based, Life
Science Knowledge Process Outsourcing (KPO) company, to deliver end-to-end
data management services in "Pharmacovigilance."
The partnership addresses the worldwide increase in focus on drug safety,
which is leading to increased volumes of adverse events being reported to the
regulatory authorities. Satyam and Sciformix will collaborate to enable
pharmaceutical and biotechnology companies to better monitor the safety of the
products they market by offering services across the safety management
spectrum, ranging from case intake to international regulatory reporting. The
alliance also enables the organizations to offer these services in a way that
is both cost-efficient and scalable, via a proven global delivery model.
Additionally, the alliance leverages Sciformix's in-depth understanding of
the pharmaceutical and life sciences domain with Satyam's proven drug safety
Business Process Outsourcing (BPO) capabilities. It will provide services to a
wide range of clients in the pharmaceutical, biotechnology and life sciences
industries.
"We are very pleased by this partnership. Sciformix has deep expertise
delivering end-to-end safety management services, from adverse event intake to
regulatory submissions," said Kishore Rachapudi, Satyam's global head of life
sciences. "We will leverage our extensive experience managing large-scale IT
and BPO solutions and work with Sciformix to offer a scalable platform for
delivery of drug safety services. At the same time, we reaffirm our commitment
to providing the widest range of services through the most advanced global
delivery models available."
Several high-profile withdrawals of popular drugs from the marketplace
have also made this partnership more important. The withdrawals have
pharmaceutical companies looking for ways to manage risk and taking a more
proactive approach toward collection and assessment of drug safety
information.
"These are some of the most important reasons we have formed this
partnership," said Dinesh Thakur, president and Chief Executive Officer of
Sciformix, "Satyam brings years of experience delivering outsourced services
to global customers. Its large-scale global delivery services capacity and
experience in the life sciences industry, along with Sciformix's deep domain
expertise, offer global pharmaceutical, biotechnology and life sciences
companies a unique alliance for delivery of high-quality services."
About Satyam
Satyam (NYSE: SAY), a leading global business and information technology
services company, delivers consulting, systems integration, and outsourcing
solutions to clients in 20* industries and 63* countries.
Satyam leverages deep industry and functional expertise, leading
technology practices, and an advanced, global delivery model to help clients
transform their highest-value business processes and improve their business
performance. The company's 51,127* professionals excel in engineering and
product development, supply chain management, client relationship management,
business process quality, business intelligence, enterprise integration, and
infrastructure management, among other key capabilities.
Satyam development and delivery centers in the US,Canada,Brazil, the UK,
Hungary,Egypt, UAE,India,China,Malaysia,Singapore, andAustralia serve
654* clients, including more than one third of the Fortune 500. For more
information, see www.satyam.com.
*As of March 31, 2008
About Sciformix Corporation
Founded in the U.S. with headquarters inWestborough, MA, and a
Pharmacovigilance Center of Excellence inMumbai, India, Sciformix is a fast
growing knowledge process outsourcing (KPO) company providing drug safety data
management, clinical data management, biostatistics & programming and medical
writing services to pharmaceutical, biotechnology and life science companies
globally. Sciformix has an experienced leadership team driving its rapid
growth and expansion. For more information on Sciformix, please visit
www.sciformix.com.
Contacts:
Satyam Computers Limited Sciformix Corporation
Rajiv Prasad, AVP Life Sciences Jeffrey S. Yablon, Vice President,
Rajiv_Prasad@satyambpo.com Sales & Marketing
jeffrey.yablon@sciformix.com
Satyam Contacts
For clarifications, write to us at MediaRelations@Satyam.com
Or contact our global PR representatives at:
India Meigha Humbre, meigha_humbre@satyam.com
+91-970-360-8822
Rachna Pandey, Rachna_pandey@satyam.com
+91-970-303-8743
US Jim Swords, james_swords@satyam.com
+1-703-877-2225
Europe Sandeep Thawani, sandeep_thawani@satyam.com
+44-20-7309-1037
Asia-Pacific Dan Bleakman, Dan@howorth.com.au
+61-439-408-484
Reshma Wad Jain, Reshma@wer1.net
+65-98-140-507
Safe Harbor
This press release contains forward-looking statements within the meaning
of section 27A of Securities Act of 1933, as amended, and section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking statements
contained herein are subject to certain risks and uncertainties that could
cause actual results to differ materially from those reflected in the forward-
looking statements. Satyam undertakes no duty to update any forward-looking
statements. For a discussion of the risks associated with our business, please
see the discussions under the heading "Risk Factors" in our report on Form 6-K
concerning the quarter ended December 31, 2007, furnished to the United States
Securities Exchange Commission on January 28, 2008 and the other reports filed
with the Securities Exchange Commission from time to time. These filings are
available at http://www.sec.gov.
This announcement is not an offer of securities for sale inthe United
States. Securities may not be offered or sold inthe United States absent
registration or an exemption from registration. Any public offering of
securities to be made inthe United States will be made by means of a
prospectus that may be obtained from Satyam and that will contain detailed
information about Satyam and its management, as well as financial statements.
SOURCE Satyam Computer Services Ltd.
Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze,
Daily News
Tags: ,CPR,HEA,BIO,ITE,MLM,CON,MA-Satyam-Comp-Servi
_ _